Evaxion Biotech has completed subject dosing in the Phase II trial of its personalised peptide-based cancer vaccine, EVX-01, for the treatment of advanced melanoma, also referred to as skin cancer.
2025
More Women And Young People Are Getting Cancer Than Before, New Report Shows
The cancer burden in the United States is shifting towards women and younger people, a new American Cancer Society study released Thursday shows, with disease rates in one group—women aged 50 to 64—surpassing those of men for the first time.
Research spotlight: Improving predictions about brain cancer outcomes with the right imaging criteria
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.”
Cobalt Oxide Nanoparticles Show Promise Against Melanoma Cells
New study reveals how cobalt oxide nanoparticles induce cancer cell death through oxidative stress and mitochondrial dysfunction.